These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9358325)

  • 21. Modeling longitudinal data, II: standard regression models and extensions.
    Ravani P; Barrett B; Parfrey P
    Methods Mol Biol; 2009; 473():61-94. PubMed ID: 19160732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications of hierarchical linear models for evaluations of health interventions: demystifying the methods and interpretations of multilevel models.
    O'Connell AA; McCoach DB
    Eval Health Prof; 2004 Jun; 27(2):119-51. PubMed ID: 15140291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the effects of interventions using longitudinal data with samples subject to selection.
    Lin HM; Hughes MD
    Biometrics; 1997 Sep; 53(3):924-36. PubMed ID: 9290223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A method for fitting regression splines with varying polynomial order in the linear mixed model.
    Edwards LJ; Stewart PW; MacDougall JE; Helms RW
    Stat Med; 2006 Feb; 25(3):513-27. PubMed ID: 16158407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An index of local sensitivity to non-ignorability for multivariate longitudinal mixed data with potential non-random dropout.
    Mahabadi SE; Ganjali M
    Stat Med; 2010 Jul; 29(17):1779-92. PubMed ID: 20658547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intention-to-treat analyses for incomplete repeated measures data.
    Hogan JW; Laird NM
    Biometrics; 1996 Sep; 52(3):1002-17. PubMed ID: 8805765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The analysis of very small samples of repeated measurements II: a modified Box correction.
    Skene SS; Kenward MG
    Stat Med; 2010 Nov; 29(27):2838-56. PubMed ID: 20860066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Group sequential clinical trials for longitudinal data with analyses using summary statistics.
    Kittelson JM; Sharples K; Emerson SS
    Stat Med; 2005 Aug; 24(16):2457-75. PubMed ID: 15977295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technical note: estimating statistical power of mixed models used in dairy nutrition experiments.
    Kononoff PJ; Hanford KJ
    J Dairy Sci; 2006 Oct; 89(10):3968-71. PubMed ID: 16960072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed-effects models for the evaluation of long-term trends in exposure levels with an example from the nickel industry.
    Symanski E; Chan W; Chang CC
    Ann Occup Hyg; 2001 Jan; 45(1):71-81. PubMed ID: 11137701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample size/power calculations for population pharmacodynamic experiments involving repeated-count measurements.
    Ogungbenro K; Aarons L
    J Biopharm Stat; 2010 Sep; 20(5):1026-42. PubMed ID: 20721789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generalizability in nongaussian longitudinal clinical trial data based on generalized linear mixed models.
    Vangeneugden T; Molenberghs G; Laenen A; Alonso A; Geys H
    J Biopharm Stat; 2008; 18(4):691-712. PubMed ID: 18607802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local influence in linear mixed models.
    Lesaffre E; Verbeke G
    Biometrics; 1998 Jun; 54(2):570-82. PubMed ID: 9629645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trials simulation: a statistical approach.
    Westfall PH; Tsai K; Ogenstad S; Tomoiaga A; Moseley S; Lu Y
    J Biopharm Stat; 2008; 18(4):611-30. PubMed ID: 18607794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of an outcome using trajectories estimated from a linear mixed model.
    Maruyama N; Takahashi F; Takeuchi M
    J Biopharm Stat; 2009 Sep; 19(5):779-90. PubMed ID: 20183443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.
    Yang X; Shoptaw S
    Drug Alcohol Depend; 2005 Mar; 77(3):213-25. PubMed ID: 15734221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Joint analysis of longitudinal data with informative right censoring.
    Liu M; Ying Z
    Biometrics; 2007 Jun; 63(2):363-71. PubMed ID: 17425632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quadratic inference functions in marginal models for longitudinal data.
    Song PX; Jiang Z; Park E; Qu A
    Stat Med; 2009 Dec; 28(29):3683-96. PubMed ID: 19757486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An approximate generalized linear model with random effects for informative missing data.
    Follmann D; Wu M
    Biometrics; 1995 Mar; 51(1):151-68. PubMed ID: 7766771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bivariate linear mixed models using SAS proc MIXED.
    Thiébaut R; Jacqmin-Gadda H; Chêne G; Leport C; Commenges D
    Comput Methods Programs Biomed; 2002 Nov; 69(3):249-56. PubMed ID: 12204452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.